Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry by Crhistian-Mario Oblitas, Pablo Demelo-Rodríguez, Lucía Barrera-López, Francisco Galeano-Valle, Manuel Rubio-Rivas, Jairo Luque del Pino, Vicente Giner Galvañ, Diana Paredes-Ruíz, Rosa Fernández-Madera Martínez, Martín Gericó Aseguinolaza, Ricardo Gómez-Huelgas, Francisco Arnalich Fernández, José David Torres Peña, José Ignacio Martín González, Manuel Méndez-Bailón, Daniel Monge Monge, Santiago J. Freire Castro, Cruz Pastor Valverde, Enrique Rodilla-Sala, Marcos Guzmán García, María Rivas-Carmenado, César-Manuel Gallo, Marina Amparo Perea Ribis, José-Manuel Casas-Rojo, Jesús Millán Núñez-Cortés, SEMICOVID-19 Network

Get full text